Document Detail

Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
MedLine Citation:
PMID:  20636314     Owner:  NLM     Status:  MEDLINE    
Atrial fibrillation (AF) is a source of considerable morbidity and mortality. There has been compelling evidence supporting the role of renin-angiotensin system (RAS) in the genesis and perpetuation of AF through atrial remodeling, and experimental studies have validated the utilization of RAS inhibition for AF prevention. This article reviews clinical trials on the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) for the prevention of AF. Results have been variable, depending on the clinical background of treated patients. ACEIs and ARBs appear beneficial for primary prevention of AF in patients with heart failure, whereas they are not equally effective in hypertensive patients with normal left ventricular function. Furthermore, the use of ACEIs or ARBs for secondary prevention of AF has been found beneficial only after electrical cardioversion. Additional data are needed to establish the potential clinical role of renin-angiotensin inhibition for prevention of AF.
Theodoros Zografos; Demosthenes G Katritsis
Related Documents :
20305314 - The influence of cardiac rhythm type and frequency on the prognosis of severe heart fai...
18810714 - Atrial conduction and atrial fibrillation: what can we learn from surface ecg?
10210494 - Right atrial focal atrial fibrillation: electrophysiologic characteristics and radiofre...
14631054 - Rate or rhythm control in persistent atrial fibrillation?
20837904 - Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodel...
19627174 - Reduced susceptibility to ischemia-induced arrhythmias in the preconditioned rat heart ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pacing and clinical electrophysiology : PACE     Volume:  33     ISSN:  1540-8159     ISO Abbreviation:  Pacing Clin Electrophysiol     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-30     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7803944     Medline TA:  Pacing Clin Electrophysiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1270-85     Citation Subset:  IM    
Copyright Information:
©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.
Department of Cardiology, Athens Euroclinic, 9 Athanassiadou Street, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Atrial Fibrillation / genetics,  physiopathology,  prevention & control*
Clinical Trials as Topic
Peptidyl-Dipeptidase A / genetics
Renin-Angiotensin System / drug effects*,  genetics,  physiology
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; EC protein, human; EC A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Complex fractionated electrograms and AF nests in vagally mediated atrial fibrillation.
Next Document:  Tachycardia in a patient with hypertrophic cardiomyopathy and suspected ventricular preexcitation.